Ahmad J. Almalki

919 total citations
32 papers, 707 citations indexed

About

Ahmad J. Almalki is a scholar working on Molecular Biology, Toxicology and Pharmacology. According to data from OpenAlex, Ahmad J. Almalki has authored 32 papers receiving a total of 707 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 10 papers in Toxicology and 8 papers in Pharmacology. Recurrent topics in Ahmad J. Almalki's work include Psychedelics and Drug Studies (7 papers), Bioactive Compounds and Antitumor Agents (5 papers) and Bacterial biofilms and quorum sensing (5 papers). Ahmad J. Almalki is often cited by papers focused on Psychedelics and Drug Studies (7 papers), Bioactive Compounds and Antitumor Agents (5 papers) and Bacterial biofilms and quorum sensing (5 papers). Ahmad J. Almalki collaborates with scholars based in Saudi Arabia, Egypt and United States. Ahmad J. Almalki's co-authors include Tarek S. Ibrahim, Wael A. H. Hegazy, Ángela I. Calderón, Sameh S. Elhady, Jack DeRuiter, Charles R. Clark, Khaled M. Darwish, Mamdouh F. A. Mohamed, El‐Sayed Khafagy and Mаhmoud Youns and has published in prestigious journals such as SHILAP Revista de lepidopterología, Molecules and RSC Advances.

In The Last Decade

Ahmad J. Almalki

31 papers receiving 697 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ahmad J. Almalki Saudi Arabia 16 313 173 84 80 73 32 707
Jadel M. Kratz Brazil 20 407 1.3× 176 1.0× 49 0.6× 86 1.1× 111 1.5× 47 1.3k
Gloria María Molina‐Salinas Mexico 18 387 1.2× 167 1.0× 68 0.8× 79 1.0× 109 1.5× 57 989
Noélia Duarte Portugal 24 817 2.6× 130 0.8× 83 1.0× 68 0.8× 142 1.9× 70 1.4k
Fatma M. Abdel Bar Egypt 16 421 1.3× 105 0.6× 37 0.4× 69 0.9× 96 1.3× 70 833
Edeildo Ferreira da Silva‐Júnior Brazil 23 451 1.4× 391 2.3× 57 0.7× 42 0.5× 89 1.2× 93 1.3k
Milan Mladenović Serbia 19 319 1.0× 292 1.7× 33 0.4× 57 0.7× 145 2.0× 45 977
Alexandros Patsilinakos Italy 18 285 0.9× 189 1.1× 23 0.3× 29 0.4× 72 1.0× 28 704
Ángela I. Calderón United States 22 430 1.4× 130 0.8× 32 0.4× 111 1.4× 163 2.2× 76 1.2k
Khaled M. Darwish Egypt 21 646 2.1× 319 1.8× 55 0.7× 84 1.1× 137 1.9× 72 1.4k
Devadasan Velmurugan India 19 555 1.8× 198 1.1× 28 0.3× 42 0.5× 105 1.4× 73 1.1k

Countries citing papers authored by Ahmad J. Almalki

Since Specialization
Citations

This map shows the geographic impact of Ahmad J. Almalki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ahmad J. Almalki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ahmad J. Almalki more than expected).

Fields of papers citing papers by Ahmad J. Almalki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ahmad J. Almalki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ahmad J. Almalki. The network helps show where Ahmad J. Almalki may publish in the future.

Co-authorship network of co-authors of Ahmad J. Almalki

This figure shows the co-authorship network connecting the top 25 collaborators of Ahmad J. Almalki. A scholar is included among the top collaborators of Ahmad J. Almalki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ahmad J. Almalki. Ahmad J. Almalki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Almalki, Ahmad J., et al.. (2023). Design, Synthesis and Anticancer Evaluation of New 1-allyl-4-oxo-6-(3,4,5-trimethoxyphenyl)-1,4-dihydropyrimidine-5-carbonitrile Bearing PyrazoleMoieties. Current Organic Synthesis. 20(8). 897–909. 1 indexed citations
4.
Nafie, Mohamed S., Amal M. Sindi, Ahmad J. Almalki, et al.. (2023). Analysis of Marrubiin in Marrubium alysson L. Extract Using Advanced HPTLC: Chemical Profiling, Acetylcholinesterase Inhibitory Activity, and Molecular Docking. Metabolites. 14(1). 27–27. 6 indexed citations
5.
Elhady, Sameh S., Khaled M. Darwish, Radi A. Mohamed, et al.. (2023). Molecular and Biological Investigation of Isolated Marine Fungal Metabolites as Anticancer Agents: A Multi-Target Approach. Metabolites. 13(2). 162–162. 4 indexed citations
7.
Girgis, Adel S., Noura M. Abo Shama, Sara H. Mahmoud, et al.. (2022). Synthesis of Potential Antiviral Agents for SARS-CoV-2 Using Molecular Hybridization Approach. Molecules. 27(18). 5923–5923. 15 indexed citations
8.
Almalki, Ahmad J., Tarek S. Ibrahim, Sameh S. Elhady, Wael A. H. Hegazy, & Khaled M. Darwish. (2022). Computational and Biological Evaluation of β-Adrenoreceptor Blockers as Promising Bacterial Anti-Virulence Agents. Pharmaceuticals. 15(2). 110–110. 40 indexed citations
9.
Almalki, Ahmad J., Tarek S. Ibrahim, Ehab S. Taher, et al.. (2022). Synthesis, Antimicrobial, Anti-Virulence and Anticancer Evaluation of New 5(4H)-Oxazolone-Based Sulfonamides. Molecules. 27(3). 671–671. 49 indexed citations
10.
Almalki, Ahmad J., Tarek S. Ibrahim, Sameh S. Elhady, Khaled M. Darwish, & Wael A. H. Hegazy. (2022). Repurposing α-Adrenoreceptor Blockers as Promising Anti-Virulence Agents in Gram-Negative Bacteria. Antibiotics. 11(2). 178–178. 34 indexed citations
11.
Elfaky, Mahmoud A., Abrar K. Thabit, Khalid Eljaaly, et al.. (2022). Controlling of Bacterial Virulence: Evaluation of Anti-Virulence Activities of Prazosin against Salmonella enterica. Antibiotics. 11(11). 1585–1585. 22 indexed citations
12.
Almalki, Ahmad J., et al.. (2021). GC–MS and GC–IR analysis of substituted N-benzyl 4-bromo-2,5-dimethoxyphenylisopropylamines. Forensic Chemistry. 24. 100326–100326. 7 indexed citations
13.
Elhady, Sameh S., Reda F. A. Abdelhameed, Abdulrahman M. Alahdal, et al.. (2021). Molecular Docking and Dynamics Simulation Study of Hyrtios erectus Isolated Scalarane Sesterterpenes as Potential SARS-CoV-2 Dual Target Inhibitors. Biology. 10(5). 389–389. 49 indexed citations
14.
Khayyat, Ahdab N., Wael A. H. Hegazy, Moataz A. Shaldam, et al.. (2021). Xylitol Inhibits Growth and Blocks Virulence in Serratia marcescens. Microorganisms. 9(5). 1083–1083. 41 indexed citations
15.
Youns, Mаhmoud, Momen Askoura, Hisham A. Abbas, et al.. (2021). Celastrol Modulates Multiple Signaling Pathways to Inhibit Proliferation of Pancreatic Cancer via DDIT3 and ATF3 Up-Regulation and RRM2 and MCM4 Down-Regulation. OncoTargets and Therapy. Volume 14. 3849–3860. 45 indexed citations
16.
Askoura, Momen, Ahmad J. Almalki, Amr S. Abu Lila, et al.. (2021). Alteration of Salmonella enterica Virulence and Host Pathogenesis through Targeting sdiA by Using the CRISPR-Cas9 System. Microorganisms. 9(12). 2564–2564. 50 indexed citations
17.
Almalki, Ahmad J., et al.. (2020). Vapor phase infrared identification of regioisomeric N-(dimethoxybenzyl)-4-iodo- and 4-bromo-2,5-dimethoxyphenethylamines. Forensic Chemistry. 19. 100239–100239. 7 indexed citations
18.
Almalki, Ahmad J., et al.. (2020). GC–MS analysis of methylenedioxybenzyl analogues of the serotonin receptor agonists 25X-NBOMe drugs. Forensic Chemistry. 21. 100284–100284. 3 indexed citations
19.
Almalki, Ahmad J., Charles R. Clark, & Jack DeRuiter. (2019). Structure fragmentation studies of ring‐substituted N ‐trifluoroacetyl‐ N ‐benzylphenethylamines related to the NBOMe drugs. Rapid Communications in Mass Spectrometry. 34(4). e8593–e8593. 7 indexed citations
20.
Almalki, Ahmad J., Charles R. Clark, & Jack DeRuiter. (2019). GC–MS analysis of regioisomeric substituted N-benzyl-4-bromo-2,5-dimethoxyphenethylamines. Forensic Chemistry. 14. 100164–100164. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026